Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Taxes (2023 - 2025)

China Pharma Holdings filings provide 7 years of Current Taxes readings, the most recent being $351904.0 for Q4 2025.

  • On a quarterly basis, Current Taxes fell 20.21% to $351904.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $351904.0, a 20.21% decrease, with the full-year FY2025 number at $351904.0, down 20.21% from a year prior.
  • Current Taxes hit $351904.0 in Q4 2025 for China Pharma Holdings, down from $691677.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.0 million in Q4 2023 to a low of $351904.0 in Q4 2025.
  • Median Current Taxes over the past 3 years was $555142.0 (2025), compared with a mean of $601079.9.
  • Biggest five-year swings in Current Taxes: crashed 57.06% in 2024 and later skyrocketed 73.26% in 2025.
  • China Pharma Holdings' Current Taxes stood at $1.0 million in 2023, then crashed by 57.06% to $441062.0 in 2024, then decreased by 20.21% to $351904.0 in 2025.
  • The last three reported values for Current Taxes were $351904.0 (Q4 2025), $691677.0 (Q3 2025), and $741376.0 (Q2 2025) per Business Quant data.